Calverley Peter M A

Top coauthors of Calverley Peter M A

Vestbo Jørgen (31 papers)

Tal-Singer Ruth (22 papers)

Crim Courtney (21 papers)

Yates Julie C (19 papers)

Rennard Stephen I (18 papers)

List of Calverley Peter M A publications

2018

Anzueto Antonio, Calverley Peter M A, Mueller Achim, Metzdorf Norbert, Haensel Michaela, et al. 2018. "Demographic Characteristics and Clinical Outcomes in Patients from Latin America Versus the Rest of the World: A TIOSPIR® Post-Hoc Analysis." Archivos de bronconeumologia doi:10.1016/j.arbres.2017.11.010

2017

Calverley Peter M A, Magnussen Helgo, Miravitlles Marc, Wedzicha Jadwiga A 2017. "Triple Therapy in COPD: What We Know and What We Don't." COPD 14 (6) doi:10.1080/15412555.2017.1389875
Dal Negro Roberto W, Wedzicha Jadwiga A, Iversen Martin, Fontana Giovanni, Page Clive, et al. 2017. "Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study." The European respiratory journal 50 (4) doi:10.1183/13993003.00711-2017
Crim Courtney, Calverley Peter M A, Anderson Julie A, Holmes Andrew P, Kilbride Sally, et al. 2017. "Pneumonia risk with inhaled fluticasone furoate and vilanterol in COPD patients with moderate airflow limitation: The SUMMIT trial." Respiratory medicine 131 doi:10.1016/j.rmed.2017.07.060
Calverley Peter M A, Mueller Achim, Fowler Andrew, Metzdorf Norbert, Wise Robert A 2017. "The Effect of Defining COPD by the Lower Limit of Normal of FEV1/FVC Ratio in TIOSPIR® Participants." Annals of the American Thoracic Society doi:10.1513/AnnalsATS.201703-194OC
Wedzicha Jadwiga A, Calverley Peter M A, Albert Richard K, Anzueto Antonio, Criner Gerard J, et al. 2017. "Prevention of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline." The European respiratory journal 50 (3) doi:10.1183/13993003.02265-2016
Calverley Peter M A, Sethi Sanjay, Dawson Michelle, Ward Christine K, Finch Donna K, et al. 2017. "A randomised, placebo-controlled trial of anti-interleukin-1 receptor 1 monoclonal antibody MEDI8968 in chronic obstructive pulmonary disease." Respiratory research 18 (1) doi:10.1186/s12931-017-0633-7
Spina Gabriele, Spruit Martijn A, Alison Jennifer, Benzo Roberto P, Calverley Peter M A, et al. 2017. "Analysis of nocturnal actigraphic sleep measures in patients with COPD and their association with daytime physical activity." Thorax 72 (8) doi:10.1136/thoraxjnl-2016-208900
Calverley Peter M A, Anderson Julie A, Brook Robert D, Crim Courtney, Gallot Natacha, et al. 2017. "Fluticasone Furoate, Vilanterol and Lung Function Decline in Patients with Moderate COPD and Heightened Cardiovascular Risk." American journal of respiratory and critical care medicine doi:10.1164/rccm.201610-2086OC
Murphy Patrick B, Rehal Sunita, Arbane Gill, Bourke Stephen, Calverley Peter M A, et al. 2017. "Effect of Home Noninvasive Ventilation With Oxygen Therapy vs Oxygen Therapy Alone on Hospital Readmission or Death After an Acute COPD Exacerbation: A Randomized Clinical Trial." JAMA 317 (21) doi:10.1001/jama.2017.4451
Wedzicha Jadwiga A, Miravitlles Marc, Hurst John R, Calverley Peter M A, Albert Richard K, et al. 2017. "Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline." The European respiratory journal 49 (3) doi:10.1183/13993003.00791-2016

2016

Andrianopoulos Vasileios, Celli Bartolome R, Franssen Frits M E, Pinto-Plata Victor M, Calverley Peter M A, et al. 2016. "Determinants of exercise-induced oxygen desaturation including pulmonary emphysema in COPD: Results from the ECLIPSE study." Respiratory medicine 119 doi:10.1016/j.rmed.2016.08.023
Joppa Pavol, Tkacova Ruzena, Franssen Frits M E, Hanson Corrine, Rennard Stephen I, et al. 2016. "Sarcopenic Obesity, Functional Outcomes, and Systemic Inflammation in Patients With Chronic Obstructive Pulmonary Disease." Journal of the American Medical Directors Association doi:10.1016/j.jamda.2016.03.020
Vestbo Jørgen, Anderson Julie A, Brook Robert D, Calverley Peter M A, Celli Bartolome R, et al. 2016. "Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial." Lancet (London, England) 387 (10030) doi:10.1016/S0140-6736(16)30069-1
Watz Henrik, Tetzlaff Kay, Wouters Emiel F M, Kirsten Anne, Magnussen Helgo, et al. 2016. "Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial." The Lancet. Respiratory medicine doi:10.1016/S2213-2600(16)00100-4
Calverley Peter M A, Könen-Bergmann Michael, Richard Frank, Bell Susan, Hohlfeld Jens M 2016. "Tiotropium Respimat(®) Versus HandiHaler(®): Comparison of Bronchodilator Efficacy of Various Doses in Clinical Trials." Advances in therapy doi:10.1007/s12325-016-0322-9
Barnes Neil C, Sharma Raj, Lettis Sally, Calverley Peter M A 2016. "Blood eosinophils as a marker of response to inhaled corticosteroids in COPD." The European respiratory journal doi:10.1183/13993003.01370-2015
Calverley Peter M A, Rennard Stephen I, Clerisme-Beaty Emmanuelle, Metzdorf Norbert, Zubek Valentina Bayer, ZuWallack Richard 2016. "Effect of tiotropium on night-time awakening and daily rescue medication use in patients with COPD." Respiratory research 17 (1) doi:10.1186/s12931-016-0340-9

2015

Walker Paul P, Thwaite Erica, Amin Suzanne, Curtis John M, Calverley Peter M A 2015. "The Association Between Heroin Inhalation and Early Onset Emphysema." Chest 148 (5) doi:10.1378/chest.15-0236
Brill Simon E, Law Martin, El-Emir Ethaar, Allinson James P, James Phillip, et al. 2015. "Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trial." Thorax 70 (10) doi:10.1136/thoraxjnl-2015-207194
De Soyza Anthony, Calverley Peter M A 2015. "Large trials, new knowledge: the changing face of COPD management." The European respiratory journal 45 (6) doi:10.1183/09031936.00179714
Martinez Fernando J, Calverley Peter M A, Goehring Udo-Michael, Brose Manja, Fabbri Leonardo M, Rabe Klaus F 2015. "Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial." Lancet (London, England) 385 (9971) doi:10.1016/S0140-6736(14)62410-7
Rennard Stephen I, Locantore Nicholas, Delafont Bruno, Tal-Singer Ruth, Silverman Edwin K, et al. 2015. "Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis." Annals of the American Thoracic Society 12 (3) doi:10.1513/AnnalsATS.201403-125OC
Aarli Bernt B, Calverley Peter M A, Jensen Robert L, Eagan Tomas M L, Bakke Per S, Hardie Jon A 2015. "Variability of within-breath reactance in COPD patients and its association with dyspnoea." The European respiratory journal 45 (3) doi:10.1183/09031936.00051214
Dahl Ronald, Calverley Peter M A, Anzueto Antonio, Metzdorf Norbert, Fowler Andy, et al. 2015. "Safety and efficacy of tiotropium in patients switching from HandiHaler to Respimat in the TIOSPIR trial." BMJ open 5 (12) doi:10.1136/bmjopen-2015-009015
Wise Robert, Calverley Peter M A, Dahl Ronald, Dusser Daniel, Metzdorf Norbert, et al. 2015. "Safety and efficacy of tiotropium Respimat versus HandiHaler in patients naive to treatment with inhaled anticholinergics: a post hoc analysis of the TIOSPIR trial." NPJ primary care respiratory medicine 25 doi:10.1038/npjpcrm.2015.67
Crim Courtney, Dransfield Mark T, Bourbeau Jean, Jones Paul W, Hanania Nicola A, et al. 2015. "Pneumonia risk with inhaled fluticasone furoate and vilanterol compared with vilanterol alone in patients with COPD." Annals of the American Thoracic Society 12 (1) doi:10.1513/AnnalsATS.201409-413OC

2014

McDonald Merry-Lynn N, Cho Michael H, Sørheim Inga-Cecilie, Lutz Sharon M, Castaldi Peter J, et al. 2014. "Common genetic variants associated with resting oxygenation in chronic obstructive pulmonary disease." American journal of respiratory cell and molecular biology 51 (5) doi:10.1165/rcmb.2014-0135OC
Magnussen Helgo, Disse Bernd, Rodriguez-Roisin Roberto, Kirsten Anne, Watz Henrik, et al. 2014. "Withdrawal of inhaled glucocorticoids and exacerbations of COPD." The New England journal of medicine 371 (14) doi:10.1056/NEJMoa1407154
Mohan Divya, Gale Nichola S, McEniery Carmel M, Bolton Charlotte E, Cockcroft John R, et al. 2014. "Evaluating the role of inflammation in chronic airways disease: the ERICA study." COPD 11 (5) doi:10.3109/15412555.2014.898031
Williams Michelle C, Murchison John T, Edwards Lisa D, Agustí Alvar, Bakke Per, et al. 2014. "Coronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortality." Thorax 69 (8) doi:10.1136/thoraxjnl-2012-203151
Faner Rosa, Tal-Singer Ruth, Riley John H, Celli Bartolomé, Vestbo Jørgen, et al. 2014. "Lessons from ECLIPSE: a review of COPD biomarkers." Thorax 69 (7) doi:10.1136/thoraxjnl-2013-204778
Dong Yaa-Hui, Chang Chia-Hsuin, Lin Wu Fe-Lin, Shen Li-Jiuan, Calverley Peter M A, et al. 2014. "Use of inhaled corticosteroids in patients with COPD and the risk of TB and influenza: A systematic review and meta-analysis of randomized controlled trials. a systematic review and meta-analysis of randomized controlled trials." Chest 145 (6) doi:10.1378/chest.13-2137
Vestbo Jørgen, Agusti Alvar, Wouters Emiel F M, Bakke Per, Calverley Peter M A, et al. 2014. "Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team." American journal of respiratory and critical care medicine 189 (9) doi:10.1164/rccm.201311-2006PP
Magnussen Helgo, Watz Henrik, Kirsten Anne, Decramer Marc, Dahl Ronald, et al. 2014. "Stepwise withdrawal of inhaled corticosteroids in COPD patients receiving dual bronchodilation: WISDOM study design and rationale." Respiratory medicine 108 (4) doi:10.1016/j.rmed.2014.01.002
Hanania Nicola A, Calverley Peter M A, Dransfield Mark T, Karpel Jill P, Brose Manja, et al. 2014. "Pooled subpopulation analyses of the effects of roflumilast on exacerbations and lung function in COPD." Respiratory medicine 108 (2) doi:10.1016/j.rmed.2013.09.018
Hersh Craig P, Make Barry J, Lynch David A, Barr R Graham, Bowler Russell P, et al. 2014. "Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitus." BMC pulmonary medicine 14 doi:10.1186/1471-2466-14-164
Rennard Stephen I, Sun Shawn X, Tourkodimitris Stavros, Rowe Paul, Goehring Udo M, et al. 2014. "Roflumilast and dyspnea in patients with moderate to very severe chronic obstructive pulmonary disease: a pooled analysis of four clinical trials." International journal of chronic obstructive pulmonary disease 9 doi:10.2147/COPD.S55738

2013

Savi Daniela, Quattrucci Serena, Internullo Mattia, De Biase Riccardo V, Calverley Peter M A, Palange Paolo 2013. "Measuring habitual physical activity in adults with cystic fibrosis." Respiratory medicine 107 (12) doi:10.1016/j.rmed.2013.09.012
Calverley Peter M A, Albert Paul, Walker Paul P 2013. "Bronchodilator reversibility in chronic obstructive pulmonary disease: use and limitations." The Lancet. Respiratory medicine 1 (7) doi:10.1016/S2213-2600(13)70086-9
Miller Joy, Edwards Lisa D, Agustí Alvar, Bakke Per, Calverley Peter M A, et al. 2013. "Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort." Respiratory medicine 107 (9) doi:10.1016/j.rmed.2013.05.001
Agusti Alvar, Edwards Lisa D, Celli Bartolomé, Macnee William, Calverley Peter M A, et al. 2013. "Characteristics, stability and outcomes of the gold 2011 copd groups in the eclipse cohort." The European respiratory journal doi:10.1183/09031936.00195212
Dransfield Mark T, Bourbeau Jean, Jones Paul W, Hanania Nicola A, Mahler Donald A, et al. 2013. "Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials." The Lancet. Respiratory medicine 1 (3) doi:10.1016/S2213-2600(13)70040-7
Vestbo Jørgen, Anderson Julie, Brook Robert D, Calverley Peter M A, Celli Bartolome R, et al. 2013. "The Study to Understand Mortality and Morbidity in COPD (SUMMIT) study protocol." The European respiratory journal 41 (5) doi:10.1183/09031936.00087312
Wedzicha Jadwiga A, Rabe Klaus F, Martinez Fernando J, Bredenbröker Dirk, Brose Manja, et al. 2013. "Efficacy of Roflumilast in the COPD Frequent Exacerbator Phenotype." Chest 143 (5) doi:10.1378/chest.12-1489
Martinez Fernando J, Boscia Joseph, Feldman Gregory, Scott-Wilson Catherine, Kilbride Sally, et al. 2013. "Fluticasone furoate/vilanterol (100/25; 200/25 μg) improves lung function in COPD: a randomised trial." Respiratory medicine 107 (4) doi:10.1016/j.rmed.2012.12.016
Priori Rita, Aliverti Andrea, Albuquerque André L, Quaranta Marco, Albert Paul, Calverley Peter M A 2013. "The effect of posture on asynchronous chest wall movement in COPD." Journal of applied physiology (Bethesda, Md. : 1985) 114 (8) doi:10.1152/japplphysiol.00414.2012
Polkey Michael I, Spruit Martijn A, Edwards Lisa D, Watkins Michael L, Pinto-Plata Victor, et al. 2013. "Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization." American journal of respiratory and critical care medicine 187 (4) doi:10.1164/rccm.201209-1596OC
White William B, Cooke Glen E, Kowey Peter R, Calverley Peter M A, Bredenbröker Dirk, et al. 2013. "Cardiovascular Safety In Patients Receiving Roflumilast for the Treatment of Chronic Obstructive Pulmonary Disease." Chest doi:10.1378/chest.12-2332
Barnes Neil, Calverley Peter M A, Kaplan Alan, Rabe Klaus F 2013. "Chronic obstructive pulmonary disease and exacerbations: patient insights from the global Hidden Depths of COPD survey." BMC pulmonary medicine 13 doi:10.1186/1471-2466-13-54
Donaldson Gavin C, Müllerova Hanna, Locantore Nicholas, Hurst John R, Calverley Peter M A, et al. 2013. "Factors associated with change in exacerbation frequency in COPD." Respiratory research 14 doi:10.1186/1465-9921-14-79
Rutten Erica P A, Calverley Peter M A, Casaburi Richard, Agusti Alvar, Bakke Per, et al. 2013. "Changes in body composition in patients with chronic obstructive pulmonary disease: do they influence patient-related outcomes?" Annals of nutrition & metabolism 63 (3) doi:10.1159/000353211

2012

Crawford Megan R, Bartlett Delwyn J, Coughlin Steven R, Phillips Craig L, Neill Alister M, et al. 2012. "The effect of continuous positive airway pressure usage on sleepiness in obstructive sleep apnoea: real effects or expectation of benefit?" Thorax 67 (10) doi:10.1136/thoraxjnl-2012-201622
Waschki Benjamin, Spruit Martijn A, Watz Henrik, Albert Paul S, Shrikrishna Dinesh, et al. 2012. "Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter study." Respiratory medicine 106 (4) doi:10.1016/j.rmed.2011.10.022
Spruit Martijn A, Polkey Michael I, Celli Bartolome, Edwards Lisa D, Watkins Michael L, et al. 2012. "Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease." Journal of the American Medical Directors Association 13 (3) doi:10.1016/j.jamda.2011.06.009
Cho Michael H, Castaldi Peter J, Wan Emily S, Siedlinski Mateusz, Hersh Craig P, et al. 2012. "A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13." Human molecular genetics 21 (4) doi:10.1093/hmg/ddr524
Calverley Peter M A, Martinez Fernando J, Fabbri Leonardo M, Goehring Udo-Michael, Rabe Klaus F 2012. "Does roflumilast decrease exacerbations in severe COPD patients not controlled by inhaled combination therapy? The REACT study protocol." International journal of chronic obstructive pulmonary disease 7 doi:10.2147/COPD.S31100
Agustí Alvar, Edwards Lisa D, Rennard Stephen I, MacNee William, Tal-Singer Ruth, et al. 2012. "Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype." PloS one 7 (5) doi:10.1371/journal.pone.0037483

2011

Vestbo Jørgen, Edwards Lisa D, Scanlon Paul D, Yates Julie C, Agusti Alvar, et al. 2011. "Changes in forced expiratory volume in 1 second over time in COPD." The New England journal of medicine 365 (13) doi:10.1056/NEJMoa1105482
Crim Courtney, Celli Bartolome, Edwards Lisa D, Wouters Emiel, Coxson Harvey O, et al. 2011. "Respiratory system impedance with impulse oscillometry in healthy and COPD subjects: ECLIPSE baseline results." Respiratory medicine 105 (7) doi:10.1016/j.rmed.2011.01.010
Calverley Peter M A, Stockley Robert A, Seemungal Terence A R, Hagan Gerry, Willits Lisa R, et al. 2011. "Reported pneumonia in patients with COPD: findings from the INSPIRE study." Chest 139 (3) doi:10.1378/chest.09-2992
Celli Bartolome, Vestbo Jörgen, Jenkins Christine R, Jones Paul W, Ferguson Gary T, et al. 2011. "Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experience." American journal of respiratory and critical care medicine 183 (3) doi:10.1164/rccm.201004-0665OC
Rennard Stephen I, Calverley Peter M A, Goehring Udo M, Bredenbröker Dirk, Martinez Fernando J 2011. "Reduction of exacerbations by the PDE4 inhibitor roflumilast--the importance of defining different subsets of patients with COPD." Respiratory research 12 doi:10.1186/1465-9921-12-18
Chakrabarti Biswajit, Purkait Sabita, Gun Punyabrata, Moore Vicky C, Choudhuri Samadrita, et al. 2011. "Chronic airflow limitation in a rural Indian population: etiology and relationship to body mass index." International journal of chronic obstructive pulmonary disease 6 doi:10.2147/COPD.S24113

2010

Sørheim Inga-Cecilie, Bakke Per, Gulsvik Amund, Pillai Sreekumar G, Johannessen Ane, et al. 2010. "α₁-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts." Chest 138 (5) doi:10.1378/chest.10-0746
Hersh Craig P, Pillai Sreekumar G, Zhu Guohua, Lomas David A, Bakke Per, et al. 2010. "Multistudy fine mapping of chromosome 2q identifies XRCC5 as a chronic obstructive pulmonary disease susceptibility gene." American journal of respiratory and critical care medicine 182 (5) doi:10.1164/rccm.200910-1586OC
Calverley Peter M A, Anderson Julie A, Celli Bartolome, Ferguson Gary T, Jenkins Christine, et al. 2010. "Cardiovascular events in patients with COPD: TORCH study results." Thorax 65 (8) doi:10.1136/thx.2010.136077
Spruit Martijn A, Watkins Michael L, Edwards Lisa D, Vestbo Jørgen, Calverley Peter M A, et al. 2010. "Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort." Respiratory medicine 104 (6) doi:10.1016/j.rmed.2009.12.007
Heffner John E, Mularski Richard A, Calverley Peter M A 2010. "COPD performance measures: missing opportunities for improving care." Chest 137 (5) doi:10.1378/chest.09-2306
Agusti Alvar, Calverley Peter M A, Celli Bartolome, Coxson Harvey O, Edwards Lisa D, et al. 2010. "Characterisation of COPD heterogeneity in the ECLIPSE cohort." Respiratory research 11 doi:10.1186/1465-9921-11-122

2009

Ferguson Gary T, Calverley Peter M A, Anderson Julie A, Jenkins Christine R, Jones Paul W, et al. 2009. "Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study." Chest 136 (6) doi:10.1378/chest.08-3016
Chakrabarti Biswajit, Sulaiman Mohammed I, Davies Lisa, Calverley Peter M A, Warburton Christopher J, Angus Robert M 2009. "A study of patient attitudes in the United Kingdom toward ventilatory support in chronic obstructive pulmonary disease." Journal of palliative medicine 12 (11) doi:10.1089/jpm.2009.0160
Fabbri Leonardo M, Calverley Peter M A, Izquierdo-Alonso José Luis, Bundschuh Daniela S, Brose Manja, et al. 2009. "Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials." Lancet 374 (9691) doi:10.1016/S0140-6736(09)61252-6
Calverley Peter M A, Rabe Klaus F, Goehring Udo-Michael, Kristiansen Søren, Fabbri Leonardo M, Martinez Fernando J 2009. "Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials." Lancet 374 (9691) doi:10.1016/S0140-6736(09)61255-1
Sin Don D, Tashkin Donald, Zhang Xuekui, Radner Finn, Sjöbring Ulf, et al. 2009. "Budesonide and the risk of pneumonia: a meta-analysis of individual patient data." Lancet 374 (9691) doi:10.1016/S0140-6736(09)61250-2
Walker Paul P, Hadcroft Justine, Costello Richard W, Calverley Peter M A 2009. "Lung function changes following methacholine inhalation in COPD." Respiratory medicine 103 (4) doi:10.1016/j.rmed.2008.11.002
Jenkins Christine R, Jones Paul W, Calverley Peter M A, Celli Bartolome, Anderson Julie A, et al. 2009. "Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study." Respiratory research 10 doi:10.1186/1465-9921-10-59

2008

Halpin David M G, Peterson Stefan, Larsson Thomas P, Calverley Peter M A 2008. "Identifying COPD patients at increased risk of mortality: predictive value of clinical study baseline data." Respiratory medicine 102 (11) doi:10.1016/j.rmed.2008.05.007
Patel Bipen D, Coxson Harvey O, Pillai Sreekumar G, Agustí Alvar G N, Calverley Peter M A, et al. 2008. "Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease." American journal of respiratory and critical care medicine 178 (5) doi:10.1164/rccm.200801-059OC
Celli Bartolomé R, Thomas Nicola E, Anderson Julie A, Ferguson Gary T, Jenkins Christine R, et al. 2008. "Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study." American journal of respiratory and critical care medicine 178 (4) doi:10.1164/rccm.200712-1869OC
Walker Paul P, Calverley Peter M A 2008. "The volumetric response to bronchodilators in stable chronic obstructive pulmonary disease." COPD 5 (3) doi:10.1080/15412550802092928
Calverley Peter M A, Rennard Stephen, Nelson Harold S, Karpel Jill P, Abbate Eduardo H, et al. 2008. "One-year treatment with mometasone furoate in chronic obstructive pulmonary disease." Respiratory research 9 doi:10.1186/1465-9921-9-73
Wedzicha Jadwiga A, Calverley Peter M A, Seemungal Terence A, Hagan Gerry, Ansari Zainab, Stockley Robert A 2008. "The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide." American journal of respiratory and critical care medicine 177 (1) doi:10.1164/rccm.200707-973OC

2007

Calverley Peter M A, Rennard Stephen I 2007. "What have we learned from large drug treatment trials in COPD?" Lancet 370 (9589) doi:10.1016/S0140-6736(07)61381-6
Sabroe Ian, Parker Lisa C, Calverley Peter M A, Dower Steven K, Whyte Moira K B 2007. "Pathological networking: a new approach to understanding COPD." Thorax 62 (8) doi:10.1136/thx.2007.077768
Calverley Peter M A, Sanchez-Toril Fernando, McIvor Andrew, Teichmann Peter, Bredenbroeker Dirk, Fabbri Leonardo M 2007. "Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease." American journal of respiratory and critical care medicine 176 (2) doi:10.1164/rccm.200610-1563OC
Cukier Alberto, Ferreira Claudia A S, Stelmach Rafael, Ribeiro Marcos, Cortopassi Felipe, Calverley Peter M A 2007. "The effect of bronchodilators and oxygen alone and in combination on self-paced exercise performance in stable COPD." Respiratory medicine 101 (4) doi:10.1016/j.rmed.2006.08.013
Calverley Peter M A, Anderson Julie A, Celli Bartolome, Ferguson Gary T, Jenkins Christine, et al. 2007. "Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease." The New England journal of medicine 356 (8) doi:10.1056/NEJMoa063070
Chakrabarti Biswajit, Calverley Peter M A, Davies Peter D O 2007. "Tuberculosis and its incidence, special nature, and relationship with chronic obstructive pulmonary disease." International journal of chronic obstructive pulmonary disease 2 (3) doi:
Rutten-van Mölken Maureen P M H, van Nooten Floortje E, Lindemann Marion, Caeser Manfred, Calverley Peter M A 2007. "A 1-year prospective cost-effectiveness analysis of roflumilast for the treatment of patients with severe chronic obstructive pulmonary disease." PharmacoEconomics 25 (8) doi:

2006

Calverley Peter M A, Scott Stephen 2006. "Is airway inflammation in chronic obstructive pulmonary disease (COPD) a risk factor for cardiovascular events?" COPD 3 (4) doi:
Calverley Peter M A 2006. "Dynamic hyperinflation: is it worth measuring?" Proceedings of the American Thoracic Society 3 (3) doi:10.1513/pats.200508-084SF

2005

Stevenson Nicola J, Walker Paul P, Costello Richard W, Calverley Peter M A 2005. "Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease." American journal of respiratory and critical care medicine 172 (12) doi:10.1164/rccm.200504-595OC
Celli Bartolome R, Calverley Peter M A, Rennard Stephen I, Wouters Emiel F M, Agusti Alvar, et al. 2005. "Proposal for a multidimensional staging system for chronic obstructive pulmonary disease." Respiratory medicine 99 (12) doi:10.1016/j.rmed.2005.03.019
Calverley Peter M A, Nordyke Robert J, Halbert R J, Isonaka Sharon, Nonikov Dmitry 2005. "Development of a population-based screening questionnaire for COPD." COPD 2 (2) doi:
Calverley Peter M A 2005. "The role of corticosteroids in chronic obstructive pulmonary disease." Seminars in respiratory and critical care medicine 26 (2) doi:10.1055/s-2005-869542
Calverley Peter M A 2005. "Minimal clinically important difference--exacerbations of COPD." COPD 2 (1) doi:

2004

Coughlin Steven R, Mawdsley Lynn, Mugarza Julie A, Calverley Peter M A, Wilding John P H 2004. "Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome." European heart journal 25 (9) doi:10.1016/j.ehj.2004.02.021
Calverley Peter M A 2004. "Reducing the frequency and severity of exacerbations of chronic obstructive pulmonary disease." Proceedings of the American Thoracic Society 1 (2) doi:10.1513/pats.2306031
Calverley Peter M A 2004. "Effect of corticosteroids on exacerbations of asthma and chronic obstructive pulmonary disease." Proceedings of the American Thoracic Society 1 (3) doi:10.1513/pats.200402-008MS

2003

Calverley Peter M A, Spencer Sally, Willits Lisa, Burge P Sherwood, Jones Paul W 2003. "Withdrawal from treatment as an outcome in the ISOLDE study of COPD." Chest 124 (4) doi: